Skip to main content
  • COMPREHENSIVE COVID-19 VACCINATION AND EXAMINING TECHNOLOGY INTELLIGENCE

    RAPID AND STREAMLINED

    HEALTH COVERAGE SUPPORT

    Who we are Connect with us
  • COMPREHENSIVE COVID-19 VACCINATION AND EXAMINING TECHNOLOGY INTELLIGENCE

    RAPID AND STREAMLINED

    HEALTH COVERAGE SUPPORT

    Who we are Connect with us
slider image
img
Preface of

AciraLLC

AciraLLC cares for an inexpensive, suitable and predominantly a flawless confidential scheduling platform in confederation with a mighty matrix of health coverage partners like authorized consulting physicians, clinical labs and pharmacy adepts. Our COVID-19 vaccine and appointment platform can be locked either by individuals or by the employers for the safety of their workforce and by the event-planners for their attenders. Trustworthy testing and confirmation are crucial to examine in the current pandemic spread of COVID for the restoration from the disease and returning to livelihood at the earliest.

We are acutely devout into our compact benefaction to the welfare of our publics.

A matrix of authorized Labs and Pharmacies, use our podium to make the COVID-19 testing as watchful and flawless competence.

Self-regularized 2nd appointment
Raising the second appointment based on the logic on the vaccine manufacturer.

Support
Instant support through Call and email for any of your queries.

State Narrating
For Vaccination and testing, we feed rapid narrating.

Connection
We have a strong matrix connection through our platform which connects with various LIMS, State Public Health Registration Bodies and Pharmacies.

Personalization
If you have distinctive needs then we can do essential personalization that emulate your needs.

Preconceived
No need to setup any forms or logics. – Needless to setup any logics and forms.

Remittance
We accept and mitigate the remittance for confidential payers.

Flexible and Congenial
Complete process of documenting the vaccination and testing is carried out in online.

img
No front page content has been created yet.
Follow the User Guide to start building your site. Subscribe to